Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Six5 Inhibitors

Six5 inhibitors are a specialized category of chemical compounds that predominantly focus on modulating the activity of the Six5 gene. This gene, a component of the homeobox gene family, plays a critical role in the regulation and coordination of developmental processes within organisms. Inhibitors targeting Six5 function to intervene in the gene's expression or the protein's activity, thereby manipulating the cellular and molecular pathways that are orchestrated by Six5. By doing so, these inhibitors can provide valuable insights into the understanding of developmental biology, cellular differentiation, and various physiological processes. Additionally, the innovative chemical architecture of Six5 inhibitors allows for the exploration of the molecular mechanisms through which the Six5 gene exerts its influence, paving the way for refined biochemical knowledge and the elucidation of complex biological networks and systems.

The design and synthesis of Six5 inhibitors entail meticulous chemical expertise, ensuring specificity and effectiveness in modulating the target gene. These compounds are often evaluated based on their ability to bind to the active sites, influence transcriptional activities, and alter protein interactions associated with the Six5 gene. Scientific exploration involving Six5 inhibitors facilitates profound explorations into genetic regulation, contributing to a more comprehensive understanding of genetic orchestration in biological systems. Thus, Six5 inhibitors serve as powerful tools in molecular biology and genetic research, opening avenues for the study of gene functions and interactions in intricate biological processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Inhibits tyrosine kinase activity of BCR-ABL fusion protein, used for chronic myeloid leukemia (CML).

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Blocks multiple kinases, including Raf and VEGFR, suppressing tumor cell proliferation and angiogenesis in advanced cancers.

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$87.00
$135.00
$293.00
$505.00
$3827.00
42
(0)

Inhibits the epidermal growth factor receptor (EGFR) tyrosine kinase, reducing cell growth and division in lung and pancreatic cancers.

Lapatinib

231277-92-2sc-353658
100 mg
$420.00
32
(1)

Dual inhibitor of EGFR and HER2 kinases, impeding signal transduction and growth in breast cancer cells.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

Targets EGFR kinase domain, blocking cell signaling pathways, and is used in non-small cell lung cancer (NSCLC).

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Inhibits BCR-ABL and Src family kinases, affecting CML and Ph+ ALL, by blocking cancer cell proliferation and survival.

Vemurafenib

918504-65-1sc-364643
sc-364643A
10 mg
50 mg
$117.00
$423.00
11
(1)

Specifically inhibits BRAF kinase with the V600E mutation, used in melanoma therapy by blocking abnormal cell growth.

Ibrutinib

936563-96-1sc-483194
10 mg
$156.00
5
(0)

Irreversibly binds to BTK, impeding B-cell signaling and used for B-cell malignancies like CLL and mantle cell lymphoma.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$251.00
$500.00
$547.00
16
(1)

Targets JAK1 and JAK2 kinases, reducing cytokine-mediated inflammation

Abemaciclib

1231929-97-7sc-507342
10 mg
$110.00
(0)

Inhibits CDK4 and CDK6, regulating cell cycle progression, and is used for HR-positive, HER2-negative breast cancer therapy.